Balcony solar systems are quietly transforming clean energy access. Discover how plug-in solar works, its legal challenges, ...
A new U.S. autism research panel is examining potential causes of autism, sparking debate over science, policy, and the ...
Bayer’s $7.25B Roundup settlement gains initial approval in Missouri, potentially resolving thousands of cancer lawsuits tied to glyphosate exposure.
CDC faces leadership exodus amid policy disputes, raising concerns over scientific independence and outbreak readiness.
Autism researchers form an independent panel to defend evidence-based science amid controversy over changes to the U.S. federal autism advisory committee.
Major talcum powder verdicts are reshaping corporate liability, public health debates, and mass tort litigation nationwide.
A Single Shot to Shield Against Two Viruses: EMA Poised to Approve Moderna’s COVID-Flu Combo Vaccine
EMA backs Moderna’s dual COVID-19 and flu vaccine, mCombriax, paving the way for EU approval ahead of the 2026–2027 season.
Novo Nordisk slashes U.S. prices for Ozempic and Wegovy by up to 50%, reshaping access to diabetes and weight-loss care.
Brazil explores using surplus solar power for Bitcoin mining, turning renewable energy waste into economic opportunity.
Severe heart attack deaths are rising among Americans under 55, especially women. Experts warn of shifting risks and ...
Casey Means’ Surgeon General nomination sparks debate over vaccines, chronic disease policy, and the future of U.S. public health.
New data show abortion clinic closures in 2026, even in legal states, reshaping reproductive health access across the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results